Pierandrea Muglia

Pierandrea Muglia

Chief Tech/Sci/R&D Officer at SANA AB

Net worth: 387 817 $ as of 30/07/2026

60 year
Health Technology
Transportation
Commercial Services

Profile

Pierandrea Muglia is the founder of GRIN Therapeutics, Inc. Currently, Dr. Muglia is Chief Executive Officer at Ichnos SRL and Chief Medical Officer at Saniona AB starting in 2023.
Formerly, Dr. Muglia was Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A, Chief Marketing Officer at Handl Therapeutics BV, and Vice President at UCB Pharma SA (Belgium) from 2012 to 2019.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/12/2024 259,999 ( 0.19% ) 387 817 $ 30/07/2026

Pierandrea Muglia active positions

CompaniesPositionStart
SANA AB Chief Tech/Sci/R&D Officer 09/03/2025

Former positions of Pierandrea Muglia

CompaniesPositionEnd
Founder 31/08/2022
Corporate Officer/Principal 30/09/2019
Sales & Marketing -
NTG NORDIC TRANSPORT GROUP A/S Director/Board Member 27/05/2010
See the detail of Pierandrea Muglia's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

13

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Transportation

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Pierandrea Muglia